Drug Pricing

Commentary

Sanders Proposal Brings Medicare Closer To The Brink Of Collapse

President Joe Biden wants to lower Medicare’s eligibility age from 65 to 60. Now Sen. Bernie Sanders is intent on doing him one better. The Vermont socialist, the country’s leading promoter of single-payer health care, is pushing Democrats to open up Medicare to Americans as young as 55. “There are many millions of seniors …

Drug Pricing

Wayne Winegarden – A Flawed Analysis on Valuing Medicines

The Institute for Clinical and Economic Review (ICER) promotes itself as “the nation’s drug pricing watchdog.”  However, as documented in the first of a series of PRI reports, ICER’s cost-effectiveness analyses contain inappropriate methodologies and subjective judgments in determining the value of medicines.  In this podcast, PRI senior fellow Wayne …

Drug Pricing

ISSUE BRIEF: ICER Analyses Are Flawed, Undervalue Life-Saving Medicines, and Are Biased Toward Price Controls

A commonly-used analysis to determine a medicine’s value is based on flawed methodologies that would diminish innovation and access, finds a new report released today by the nonpartisan Center for Medical Economics and Innovation at the Pacific Research Institute. “Cost effectiveness reports may provide precise estimates, but there is no …

Commentary

Don’t Overreact to Rising Health Spending

U.S. healthcare spending has reached a new high, according to the latest federal data. The Centers for Medicare and Medicaid Services estimate national health expenditures reached $3.8 trillion in 2019, an increase of 4.6 percent over the previous year. That’s just under 18 percent of the national economy. It’s more …

Commentary

Biden’s health care plans – this is what Americans can expect from Democrats

Last week, President Joe Biden signed executive orders that will re-open ObamaCare’s insurance exchanges from Feb. 15 through May 15 and direct federal agencies to re-examine some of the health care rules enacted by the Trump administration. There’s a limit to what Biden can accomplish by executive action. But with narrow control of Congress, there’s still plenty …

Blog

It’s the Payment System

Effectively addressing the drug affordability problem requires an understanding of its causes. Toward this end, the rhetoric of Matt Eyles, the president and chief executive of America’s Health Insurance Plans (AHIP), is unhelpful. According to Eyles, “Americans are being hurt by out-of-control drug prices, which are set and fully controlled …

Drug Pricing

NEW BRIEF: Tearing Down Drug ‘Rebate Walls’ Would Save Patients, Improve Health Care Outcomes

Tearing down drug “rebate walls” that increase patient costs and block access to cheaper and often more effective medications would increase competition, lower out-of-pocket costs, and improve health outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. Click …

Blog

PRI’s 2020 Free-Market Election Analysis

For hard-working Californians who are busy with their everyday lives, it can be hard to sort through the various measures we’ll be voting on this November.  To help you get educated on the issues, below are links to PRI’s free-market analysis on the November ballot.  We hope you will find …

Drug Importation

NEW BRIEF: Counterfeit Drugs Harm Patients, Economy, Innovation

A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute shows that counterfeit drugs put patients in harm’s way, hinder drug innovation, and lead to job losses. Proposals like drug importation or price controls, if implemented, would exacerbate the problem and …

Commentary

Import German drug prices to the United States? Nein, danke

President Trump recently issued a blitz of executive orders in an attempt to fulfill his promise to reduce drug prices. One of those orders would put in place a “cure” far worse than the disease. The order in question establishes foreign reference pricing, whereby the federal government ties its reimbursement rates for …

Commentary

Sanders Proposal Brings Medicare Closer To The Brink Of Collapse

President Joe Biden wants to lower Medicare’s eligibility age from 65 to 60. Now Sen. Bernie Sanders is intent on doing him one better. The Vermont socialist, the country’s leading promoter of single-payer health care, is pushing Democrats to open up Medicare to Americans as young as 55. “There are many millions of seniors …

Drug Pricing

Wayne Winegarden – A Flawed Analysis on Valuing Medicines

The Institute for Clinical and Economic Review (ICER) promotes itself as “the nation’s drug pricing watchdog.”  However, as documented in the first of a series of PRI reports, ICER’s cost-effectiveness analyses contain inappropriate methodologies and subjective judgments in determining the value of medicines.  In this podcast, PRI senior fellow Wayne …

Drug Pricing

ISSUE BRIEF: ICER Analyses Are Flawed, Undervalue Life-Saving Medicines, and Are Biased Toward Price Controls

A commonly-used analysis to determine a medicine’s value is based on flawed methodologies that would diminish innovation and access, finds a new report released today by the nonpartisan Center for Medical Economics and Innovation at the Pacific Research Institute. “Cost effectiveness reports may provide precise estimates, but there is no …

Commentary

Don’t Overreact to Rising Health Spending

U.S. healthcare spending has reached a new high, according to the latest federal data. The Centers for Medicare and Medicaid Services estimate national health expenditures reached $3.8 trillion in 2019, an increase of 4.6 percent over the previous year. That’s just under 18 percent of the national economy. It’s more …

Commentary

Biden’s health care plans – this is what Americans can expect from Democrats

Last week, President Joe Biden signed executive orders that will re-open ObamaCare’s insurance exchanges from Feb. 15 through May 15 and direct federal agencies to re-examine some of the health care rules enacted by the Trump administration. There’s a limit to what Biden can accomplish by executive action. But with narrow control of Congress, there’s still plenty …

Blog

It’s the Payment System

Effectively addressing the drug affordability problem requires an understanding of its causes. Toward this end, the rhetoric of Matt Eyles, the president and chief executive of America’s Health Insurance Plans (AHIP), is unhelpful. According to Eyles, “Americans are being hurt by out-of-control drug prices, which are set and fully controlled …

Drug Pricing

NEW BRIEF: Tearing Down Drug ‘Rebate Walls’ Would Save Patients, Improve Health Care Outcomes

Tearing down drug “rebate walls” that increase patient costs and block access to cheaper and often more effective medications would increase competition, lower out-of-pocket costs, and improve health outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. Click …

Blog

PRI’s 2020 Free-Market Election Analysis

For hard-working Californians who are busy with their everyday lives, it can be hard to sort through the various measures we’ll be voting on this November.  To help you get educated on the issues, below are links to PRI’s free-market analysis on the November ballot.  We hope you will find …

Drug Importation

NEW BRIEF: Counterfeit Drugs Harm Patients, Economy, Innovation

A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute shows that counterfeit drugs put patients in harm’s way, hinder drug innovation, and lead to job losses. Proposals like drug importation or price controls, if implemented, would exacerbate the problem and …

Commentary

Import German drug prices to the United States? Nein, danke

President Trump recently issued a blitz of executive orders in an attempt to fulfill his promise to reduce drug prices. One of those orders would put in place a “cure” far worse than the disease. The order in question establishes foreign reference pricing, whereby the federal government ties its reimbursement rates for …

Scroll to Top